Capricor Therapeutics (CAPR) Misses Q1 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. APLD
7. ORCL
8. USO
9. STZ
10. AAPL

Go back to Capricor Therapeutics (CAPR) Misses Q1 EPS by 8c

Capricor Therapeutics (CAPR) PT Raised to $25 at Ladenburg Thalmann

May 14, 2024 6:46 AM EDT

Ladenburg Thalmann analyst Aydin Huseynov raised the price target on Capricor Therapeutics (NASDAQ: CAPR) to $25.00 (from $24.00) while maintaining a Buy rating.

The analyst comments "CAPR seems to have advanced in its regulatory negotiations with the FDA with possible rolling BLA... More